Our expert clinicians and researchers offer clinical-oriented R&D services at every stage of product development, from mode of action studies in disease-relevant settings, follow-up studies for target identification, and development of various types of bioassays.
The Hadassah advantage
Our technological infrastructure
enables you to carry out the entire
flow of studies under one roof
enables you to carry out the entire
flow of studies under one roof
Having Hadassah-associated key
opinion leaders as your advisors
adds authority and legitimacy to
your offering in the global academic,
scientific and investor communities
opinion leaders as your advisors
adds authority and legitimacy to
your offering in the global academic,
scientific and investor communities
Companies can retain IP
rights on technologies
developed with our services
rights on technologies
developed with our services
Various hospital units and research facilities at your disposal
Consultation with clinical specialists
- Pre-clinical design by expert professionals
- Protocol and clinical program design
- Ethical committee submissions
Disease models and
experimental animal studies
Hadassah researchers use diverse models that can be customized according to your needs
- Animal models are available for the following clinical fields:
neurodegeneration, oncology, autoimmune, epilepsy, metabolic disease, obesity, hepatic diseases, diabetes, behavior & cognitive, ophthalmology, gastroenterology, nephrology, cell-therapy, hematology, coagulation, dermatology, dental and more. - Imaging facilities for rodent models:
The Wohl National Center for Translational Medical Research - State-of-the-art operating theatres for surgical and
interventional procedures - Hadassah Organoid Center
- Ethical Review Committee for animal studies
Bioassay development
and performance
Bioassays that can be performed at Hadassah and customized for you:
- Immune functions
- Immune regulation
- Surrogate clinical end points
- Flow cytometry-based assays
- Next generation sequencing
- Mutational analysis
- Biomarkers
- Human tissue analysis – molecular/histochemical/ex-vivo cultures/primary cells with specific mutations
- Unique patient-derived cancer cell lines